The elderly population is still underrepresented in clinical trials, with nearly a third of newly registered drugs included an insufficient number of elderly participants, leading to uncertainties regarding safety and effectiveness for prescribers.
Sophie Engler
Advertisement
Articles by Sophie Engler
Advertisement
Latest Updated Articles
Are New Medicines Being Developed to Meet the Needs of the Ever-Ageing Population?Published: February 28th 2020 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
